WASHINGTON (Reuters) - U.S. health officials have approved 13 cheaper generic alternatives to Ambien, a blockbuster sleeping pill from France’s Sanofi-Aventis, the Food and Drug Administration said on Monday.The controversial drug, also known as zolpidem tartrate, has been linked to potentially dangerous risks such as driving while asleep and allergic reactions. Like Ambien and other popular sleep drugs, the new generics will also have to carry warnings on their product labels, the FDA said.>>> Discuss This Story
